Want to see IN:ALKEM full AI Analyst Report?
Alkem Laboratories Ltd. (ALKEM) Financial Statements
Alkem Laboratories Ltd. Financial Overview
Alkem Laboratories Ltd.'s market cap is currently $612.77B. The company's EPS TTM is $180.25; its P/E ratio is 28.37; and it has a dividend yield of 1.04%. Alkem Laboratories Ltd. is estimated to report earnings on November 6, 2026, and the estimated EPS forecast is $56.14. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 147.12B | $ 128.05B | $ 124.39B | $ 114.40B | $ 105.12B |
| Gross Profit | $ 96.19B | $ 79.47B | $ 74.07B | $ 64.58B | $ 62.29B |
| Operating Income | $ 26.23B | $ 21.84B | $ 19.85B | $ 13.34B | $ 17.69B |
| EBITDA | $ 34.14B | $ 29.71B | $ 24.18B | $ 17.09B | $ 21.89B |
| Net Income | $ 23.02B | $ 21.65B | $ 17.96B | $ 9.84B | $ 16.46B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 40.65B | $ 37.78B | $ 42.70B | $ 11.43B | $ 13.13B |
| Total Assets | $ 208.73B | $ 176.91B | $ 155.75B | $ 137.57B | $ 140.69B |
| Total Debt | $ 20.47B | $ 13.81B | $ 14.18B | $ 13.97B | $ 26.68B |
| Net Debt | $ 17.99B | $ 10.77B | $ 9.63B | $ 11.23B | $ 24.36B |
| Total Liabilities | $ 65.24B | $ 52.57B | $ 48.60B | $ 43.22B | $ 52.22B |
| Stockholders' Equity | $ 138.20B | $ 119.85B | $ 103.12B | $ 90.45B | $ 86.38B |
| Cash Flow | |||||
| Free Cash Flow | $ 13.46B | $ 12.37B | $ 16.89B | $ 14.50B | $ 7.72B |
| Operating Cash Flow | $ 19.63B | $ 19.13B | $ 19.48B | $ 16.82B | $ 11.11B |
| Investing Cash Flow | $ -16.67B | $ -12.99B | $ -10.09B | $ 1.13B | $ -14.35B |
| Financing Cash Flow | $ -5.03B | $ -8.11B | $ -11.45B | $ -17.61B | $ 3.80B |
Currency in INR